Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 233
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01651858 | Nurigra Chewable Tablet in Healthy Adult Male Volunteers | ||
| NCT06866509 | To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients | ||
| NCT01635686 | Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers | ||
| NCT01552954 | Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT03947528 | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions | ||
| NCT06751121 | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori | ||
| NCT05926414 | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | ||
| NCT02332044 | Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers | ||
| NCT06027307 | Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation | ||
| NCT05321732 | The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults | ||
| NCT05889026 | The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT01945684 | A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity | ||
| NCT06644404 | Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults | ||
| NCT04632862 | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | ||
| NCT01522586 | Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031 | ||
| NCT07746518 | Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis | ||
| NCT05886933 | Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet | ||
| NCT02952547 | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT03574285 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions | ||
| NCT02622685 | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects | ||
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT05660122 | A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT02369302 | Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers | ||
| NCT02952755 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers | ||
| NCT04520022 | Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB | ||
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions | ||
| NCT06109259 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers | ||
| NCT06036342 | Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination | ||
| NCT03846453 | A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes | ||
| NCT05226533 | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | ||
| NCT04592835 | To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT03024086 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia | ||
| NCT02502721 | A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 | ||
| NCT04524052 | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 | ||
| NCT04535856 | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients | ||
| NCT05607589 | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT04341454 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis | ||
| NCT04185805 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) | ||
| NCT03224117 | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT07213310 | Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults | ||
| NCT07783763 | Study of DWP450 in Japanese Subjects With Glabellar Lines | ||
| NCT04343547 | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults |
